跳至主要内容
临床试验/CTRI/2025/03/082377
CTRI/2025/03/082377尚未招募不适用

Tumor necrosis factor receptor 1(TNFR1) levels in type 2 diabetes mellitus(T2DM)and its association with levels of proteinuria

Maulana Azad Medical College1 个研究点 分布在 1 个国家目标入组 60 人开始时间: 2025年4月1日最近更新:

试验速览

阶段
不适用
状态
尚未招募
入组人数
60
试验地点
1
主要终点
Measurement of tumor necrosis factor receptor 1(TNFR1)levels in type 2 diabetes mellitus

研究概览

简要总结

Diabetic patients are at high risk of developing nephropathy (proteinuria). My study would detect association of levels of proteinuria with Tumor necrosis factor receptor 1 levels in type 2 diabetes mellitus.

It helps in early detection of nephropathy in Type 2 diabetes mellitus patients.

研究设计

研究类型
Observational

入排标准

年龄范围
40.00 Year(s) 至 99.00 Year(s)(—)
性别
All

入选标准

  • Newly diagnosed type 2 diabetes mellitus greater than 40 years of age.

排除标准

  • Chronic inflammatory conditions (SLE, RA,Psoriasis, Pyomyositis),heart failure, MI,Sepsis, pregnancy.

结局指标

主要结局

Measurement of tumor necrosis factor receptor 1(TNFR1)levels in type 2 diabetes mellitus

时间窗: 1 year

To measure levels of proteinuria in type 2 diabetes mellitus with tumor necrosis factor receptor 1

时间窗: 1 year

次要结局

  • Measurement of glycemic parameters with tumor necrosis factor receptor 1(1 year)

研究者

申办方类型
Government medical college
责任方
Principal Investigator
主要研究者

Rajat Rao

Maulana Azad Medical College,New Delhi

研究点 (1)

Loading locations...

相似试验